SynthesisJournal for immunotherapy of cancer2022

Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis.

Siqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.